Literature DB >> 2327840

Prediction of glucose response to weight loss in patients with non-insulin-dependent diabetes mellitus.

N B Watts1, R G Spanheimer, M DiGirolamo, S S Gebhart, V C Musey, Y K Siddiq, L S Phillips.   

Abstract

Although diet therapy is considered the cornerstone of therapy for obese patients with non-insulin-dependent diabetes mellitus, losing weight is often difficult, and the plasma glucose concentration does not always improve after weight loss. We looked for predictors of improvement in plasma glucose levels after weight loss in 135 obese patients with non-insulin-dependent diabetes mellitus who had lost at least 9.1 kg of body weight. After weight loss there was a bimodal distribution of plasma glucose levels, allowing us to identify patients as "responders" or "nonresponders" according to whether a random plasma glucose level was above or below 10.0 mmol/L after a 9.1-kg weight loss. Fifty-five (41%) of 135 patients were responders (after a 9.1-kg weight loss, the mean +/- SEM plasma glucose level was 7.0 +/- 0.2 mmol/L). Many responders had improved plasma glucose levels after only slight weight loss. Eighty (59%) of 135 patients were nonresponders (after a 9.1-kg weight loss, the mean +/- SEM plasma glucose level was 18.3 +/- 0.6 mmol/L). Although the responder and nonresponder groups were comparable in age, sex distribution, plasma glucose levels, and body weight at initial presentation, improvement in the plasma glucose level after weight loss could be predicted by a plasma glucose level of 10.0 mmol/L or lower after 2.3-kg (62% positive predictive value) and 4.5-kg (79% positive predictive value) weight loss. We conclude that, in contrast to conventional teaching, many patients with non-insulin-dependent diabetes mellitus will not have any improvement in plasma glucose levels after a 9.1-kg weight loss. However, a substantial minority (approximately 40%) of obese patients with non-insulin-dependent diabetes mellitus have much lower plasma glucose levels with a weight loss of 9.1 kg or less. Although the plasma glucose response to weight loss cannot be forecast by initial clinical parameters, the success or failure of diet therapy can be predicted from the plasma glucose level after a weight loss of only 2.3 to 4.5 kg. Mild or moderately obese patients with non-insulin-dependent diabetes mellitus who remain hyperglycemic after a weight loss of 2.3 to 9.1 kg are unlikely to improve with further weight loss and should be considered for treatment with insulin or oral hypoglycemic agents.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2327840

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  13 in total

1.  Is weight loss the best lifestyle intervention for type 2 diabetes?

Authors:  Marion J Franz
Journal:  Curr Diab Rep       Date:  2004-10       Impact factor: 4.810

2.  Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection.

Authors:  J M Schwarz; R A Neese; S Turner; D Dare; M K Hellerstein
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

Review 3.  Screening, prevention, counseling, and treatment for the complications of type II diabetes mellitus. Putting evidence into practice.

Authors:  S Vijan; D L Stevens; W H Herman; M M Funnell; C J Standiford
Journal:  J Gen Intern Med       Date:  1997-09       Impact factor: 5.128

4.  Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus.

Authors:  A L DePaula; A L V Macedo; N Rassi; S Vencio; C A Machado; B R Mota; L Q Silva; A Halpern; V Schraibman
Journal:  Surg Endosc       Date:  2008-03-18       Impact factor: 4.584

5.  Misunderstanding in the classification of diabetes mellitus. What's in a name?

Authors:  M L Elks; J W Sawyer
Journal:  West J Med       Date:  1993-07

6.  Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35.

Authors:  A L DePaula; A L V Macedo; N Rassi; C A Machado; V Schraibman; L Q Silva; A Halpern
Journal:  Surg Endosc       Date:  2008-03       Impact factor: 4.584

7.  Effects of basal insulin analog and metformin on glycaemia control and weight as risk factors for endothelial dysfunction.

Authors:  Belma Ascić-Buturović; Mirsad Kacila
Journal:  Bosn J Basic Med Sci       Date:  2008-11       Impact factor: 3.363

Review 8.  Evolution of diabetes medical nutrition therapy.

Authors:  M J Franz; H Warshaw; A E Daly; J Green-Pastors; M S Arnold; J Bantle
Journal:  Postgrad Med J       Date:  2003-01       Impact factor: 2.401

Review 9.  Treating diabetes and prediabetes by focusing on obesity management.

Authors:  Lalita Khaodhiar; Sue Cummings; Caroline M Apovian
Journal:  Curr Diab Rep       Date:  2009-10       Impact factor: 4.810

10.  Family versus individually oriented intervention for weight loss in Mexican American women.

Authors:  J H Cousins; D S Rubovits; J K Dunn; R S Reeves; A G Ramirez; J P Foreyt
Journal:  Public Health Rep       Date:  1992 Sep-Oct       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.